Filippos Vingopoulos MD
Anterior Segment Related, Cornea & External Disease, Refractive Surgery, Retinal Disease
Physician
Join to View Full Profile
2452 Watson CtPalo Alto, CA 94303
Phone+1 650-723-6995
Dr. Vingopoulos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of AthensClass of 2018
Certifications & Licensure
CA State Medical License 2023 - 2026
Publications & Presentations
PubMed
- Early experience and assessment of real-world toxicities with mirvetuximab soravtansine in a heavily pretreated patient cohort with ovarian cancer.Susan M Lang, Filippos Vingopoulos, Isabel Beshar, Sahana Somasegar, Elizabeth V Adams
Gynecologic Oncology Reports. 2025-06-01 - Structure-Function Associations Between Quantitative Contrast Sensitivity Function And Peripapillary Optical Coherence Tomography Angiography in Diabetic Retinopathy.Sierra K Ha, Xinyi Ding, Francesco Romano, Katherine M Overbey, Filippos Vingopoulos
Investigative Ophthalmology & Visual Science. 2025-04-01 - Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy.Melissa Yuan, Francesco Romano, Xinyi Ding, Mauricio Garcia, Itika Garg
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2025-03-01
Press Mentions
Stanford University Study Finds Ovarian Cancer Drug Can Affect the EyesOctober 23rd, 2024- AAO: Corneal Toxicity Reported with Mirvetuximab SoravtansineOctober 23rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
